Nexthera Capital’s GSK GSK Stock Holding History

Nexthera Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-286,442	Closed	-$14.5M	–	42
2017 Q3	$14.5M	Buy	286,442 +28,842	+11%	+$1.46M	3.74%	5
2017 Q2	$13.9M	Buy	257,600 +4,400	+2%	+$235K	6.05%	4
2017 Q1	$13.3M	Buy	+253,200	New	+$12.8M	6.81%	5
2016 Q4	–	Sell	-276,000	Closed	-$14.9M	–	40
2016 Q3	$14.9M	Sell	276,000 -100,000	-27%	-$5.48M	9.14%	3
2016 Q2	$20.4M	Buy	+376,000	New	+$19.8M	17.64%	2

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nexthera Capital's GSK Position: Q4 2017 in Review

Nexthera Capital sold out of GSK (GSK) in Q4 2017, closing a stake of 286,442 shares — an estimated $14.5M sold.

Nexthera Capital first reported a position in GSK in Q2 2016 and held it in 5 quarters. The position peaked at $20.4M in Q2 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

Nexthera Capital reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
Nexthera Capital sold 286,442 GSK shares in Q4 2017, an estimated $14.5M.
Nexthera Capital first reported a position in GSK in Q2 2016 and held it in 5 quarters.
Nexthera Capital's GSK position peaked at $20.4M in Q2 2016.
763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Nexthera Capital's 13F filing for Q4 2017, filed 14 Feb 2018.